Sumel Ashique , Anas Islam , Yusuf Asad2026-05-162026978-0-443-36641-3https://doi.org/10.1016/B978-0-443-36641-3.00005-Xhttp://136.232.12.194:4000/handle/123456789/1825Book Title: Extracellular Vesicle-Based Biovectors for Diagnostic and Biomedical Applications Book Editor(s): Arun Kumar, Charan Singh and Ajeet Kumar KaushikA subclass of extracellular vesicles (EVs), known as exosomes, has proven to be an effective therapeutic tool for treating a range of illnesses. EVs are nanoscale vesicle structures that are released by many types of cells. They are involved in cell signal transduction, carry a multitude of biological macromolecules, and evade immune system clearance. Exosomes are abundant in all living things and are secreted by practically all cells, which make them great candidates for a wide range of studies and applications. There are four main procedures used to isolate exosomes: centrifugation, precipitation, ultrafiltration, and immunoassay. Their primary goal is to rid the exosomes of the mixed cells, their pieces, and other tiny molecular contaminants. Nonetheless, the isolation of exosomes is extremely difficult due to their intrinsic variability, the complexity of biological fluids, and the existence of nanoscale pollutants. Conventional exosome isolation techniques are laborious, difficult, and require lengthy, intricate procedures. The development of nanolithography, electrodeposition, microfluidic chips, and other technologies has encouraged the fusion and innovation of isolation techniques. The utilization of these techniques has resulted in significant advantages for exosome isolation, including ultrafast, portable integration, and minimal loss. Clinical applications, isolation purity, and isolation yield have all seen notable functional advances.en-USextracellular vesiclesexosomesBook chapter